US 11926832
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
granted A61KA61K47/02A61K47/549
Quick answer
US patent 11926832 (Ketohexokinase (KHK) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K47/02, A61K47/549